Our previous paper is well-cited
Our article from 2015 is among the top 10% most cited PLOS ONE papers, describing the ability of PIM kinases to promote and PIM inhibitors to block metastatic growth of prostate cancer xenografts in vivo.
Our article from 2015 is among the top 10% most cited PLOS ONE papers, describing the ability of PIM kinases to promote and PIM inhibitors to block metastatic growth of prostate cancer xenografts in vivo.